C124P: Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade lecanemab biosimilar specifically binds to the amyloid-beta protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by lecanemab.C115P: Lanadelumab Biosimilar, Human KLKB1 Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade lanadelumab biosimilar specifically binds to the KLKB1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by lanadelumab.C123P: Imdevimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade imdevimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by imdevimab.C121P: Guselkumab Biosimilar, Human IL-23 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade guselkumab biosimilar specifically binds to the IL-23 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by guselkumab.C125P: Faricimab Biosimilar, Human ANGPT2/VEGFA Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade faricimab biosimilar specifically binds to the ANGPT2/VEGFA protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by faricimab.C117P: Emicizumab Biosimilar, Human F10, F9 Monoclonal Antibody
Recombinant Humanized IgG4 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade emicizumab biosimilar specifically binds to the F10, F9 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by emicizumab.C114P: Burosumab Biosimilar, Human FGF23 Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade burosumab biosimilar specifically binds to the FGF23 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by burosumab.C122P: Benralizumab Biosimilar, Human IL-5Ra Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade benralizumab biosimilar specifically binds to the IL-5 R alpha/CD125 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by benralizumab.C126P: Bedinvetmab Biosimilar, NGF/NGFB Monoclonal Antibody
Recombinant Caninized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade bedinvetmab biosimilar specifically binds to the NGF/NGFB protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bedinvetmab.C112P: Vandortuzumab Biosimilar, Anti-STEAP1 Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade vandortuzumab biosimilar specifically binds to the STEAP1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by vandortuzumab.